67
https://pubmed.ncbi.nlm.nih.gov/38117995
The scientific abstract suggests that the use of SGLT2 inhibitors for diabetes management is being explored beyond type 2 diabetes.
“Exploring SGLT2 Inhibitors for Diabetes Management Beyond Type 2”
